Carcinoma de células de Merkel metastásico: microambiente tumoral, perfil inmunogenómico y papel de la radioterapia en el abordaje oncológico
Salud Medicina e Innovación Journal · 09.11.2026 · 4 (4) · 378-395
DOI: 10.70577/smpfza05 ↗Kurz gefasst
Fachartikel in der Zeitschrift Salud Medicina e Innovación Journal, online erschienen am 09.11.2026. Verfasst von Micaela Stefanny Zúñiga Rojas und 4 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction
Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine tumor with high metastatic potential and poor prognosis in advanced stages (Valukas et al., 2026). The identification of Merkel cell polyomavirus (MCPyV) and the advent of immunotherapy have transformed the therapeutic paradigm.
Objective
To synthesize evidence on the tumor microenvironment, immunogenomic profile, and role of radiotherapy in metastatic MCC through an exploratory systematic review with PICO questions.
Methods
Exploratory systematic review following PRISMA 2020 (Page et al., 2021). Search in PubMed/MEDLINE, Europe PMC, and Scopus (January 2000 to October 2026). Studies on tumor microenvironment, genomic characterization, and radiotherapy in MCC were included.
Results
Fifty-two records were identified; after screening, 10 studies were included. Tumor microenvironment analysis revealed significant differences between MCPyV-positive and negative MCC: virus-negative tumors exhibit higher mutational burden and UV signatures, while virus-positive tumors show increased CD8+ T cell infiltration and organized immune aggregates (Donizy et al., 2021; Haist et al., 2025). Short-course radiotherapy has demonstrated abscopal responses in anti-PD-1-resistant patients (Xu et al., 2018; Bloom et al., 2019).
Conclusions
Metastatic MCC presents a heterogeneous immunogenic microenvironment conditioned by viral status. Radiotherapy emerges as a synergistic strategy with immunotherapy, with growing evidence of abscopal responses. Validated predictive biomarkers are required to optimize patient selection.
Zitieren
APA
Rojas, M. S. Z., Pacas, F. F. J., Quizhpe, A. V. P., Laguna, S. C. S., & Yáñez, L. F. R. (2026). Carcinoma de células de Merkel metastásico: microambiente tumoral, perfil inmunogenómico y papel de la radioterapia en el abordaje oncológico. Salud Medicina e Innovación Journal, 4(4), 378-395. https://doi.org/10.70577/smpfza05
Vancouver
Rojas MSZ, Pacas FFJ, Quizhpe AVP, Laguna SCS, Yáñez LFR. Carcinoma de células de Merkel metastásico: microambiente tumoral, perfil inmunogenómico y papel de la radioterapia en el abordaje oncológico. Salud Medicina e Innovación Journal. 2026;4(4):378-395. doi:10.70577/smpfza05
BibTeX
@article{Rojas2026,
author = {Rojas, Micaela Stefanny Zúñiga and Pacas, Franklin Fernando Jaramillo and Quizhpe, Alba Verónica Pullaguari and Laguna, Stephanie Carolina Santacruz and Yáñez, Luisa Fernanda Remolina},
title = {Carcinoma de células de Merkel metastásico: microambiente tumoral, perfil inmunogenómico y papel de la radioterapia en el abordaje oncológico},
journal = {Salud Medicina e Innovación Journal},
year = {2026},
volume = {4},
number = {4},
pages = {378--395},
doi = {10.70577/smpfza05}
}
EUVIMED